BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34039737)

  • 21. Loss of H3K27 methylation identifies poor outcomes in adult-onset acute leukemia.
    van Dijk AD; Hoff FW; Qiu YH; Chandra J; Jabbour E; de Bont ESJM; Horton TM; Kornblau SM
    Clin Epigenetics; 2021 Jan; 13(1):21. PubMed ID: 33509276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early Response-Based Therapy Stratification Improves Survival in Adult Early Thymic Precursor Acute Lymphoblastic Leukemia: A Group for Research on Adult Acute Lymphoblastic Leukemia Study.
    Bond J; Graux C; Lhermitte L; Lara D; Cluzeau T; Leguay T; Cieslak A; Trinquand A; Pastoret C; Belhocine M; Spicuglia S; Lheritier V; Leprêtre S; Thomas X; Huguet F; Ifrah N; Dombret H; Macintyre E; Boissel N; Asnafi V
    J Clin Oncol; 2017 Aug; 35(23):2683-2691. PubMed ID: 28605290
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TET2 as a tumor suppressor and therapeutic target in T-cell acute lymphoblastic leukemia.
    Bensberg M; Rundquist O; Selimović A; Lagerwall C; Benson M; Gustafsson M; Vogt H; Lentini A; Nestor CE
    Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34413196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reverse engineering of TLX oncogenic transcriptional networks identifies RUNX1 as tumor suppressor in T-ALL.
    Della Gatta G; Palomero T; Perez-Garcia A; Ambesi-Impiombato A; Bansal M; Carpenter ZW; De Keersmaecker K; Sole X; Xu L; Paietta E; Racevskis J; Wiernik PH; Rowe JM; Meijerink JP; Califano A; Ferrando AA
    Nat Med; 2012 Feb; 18(3):436-40. PubMed ID: 22366949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcriptome-wide subtyping of pediatric and adult T cell acute lymphoblastic leukemia in an international study of 707 cases.
    Dai YT; Zhang F; Fang H; Li JF; Lu G; Jiang L; Chen B; Mao DD; Liu YF; Wang J; Peng LJ; Feng C; Chen HF; Mu JX; Zhang QL; Wang H; Ariffin H; Moy TA; Wang JH; Lou YJ; Chen SN; Wang Q; Liu H; Shan Z; Matsumura I; Miyazaki Y; Yasuda T; Dou LP; Yan XJ; Yan JS; Yeoh AE; Wu DP; Kiyoi H; Hayakawa F; Jin J; Wang SY; Sun XJ; Mi JQ; Chen Z; Huang JY; Chen SJ
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2120787119. PubMed ID: 35385357
    [TBL] [Abstract][Full Text] [Related]  

  • 26. WT1 mutations in T-ALL.
    Tosello V; Mansour MR; Barnes K; Paganin M; Sulis ML; Jenkinson S; Allen CG; Gale RE; Linch DC; Palomero T; Real P; Murty V; Yao X; Richards SM; Goldstone A; Rowe J; Basso G; Wiernik PH; Paietta E; Pieters R; Horstmann M; Meijerink JP; Ferrando AA
    Blood; 2009 Jul; 114(5):1038-45. PubMed ID: 19494353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNMT3A(R882H) mutant and Tet2 inactivation cooperate in the deregulation of DNA methylation control to induce lymphoid malignancies in mice.
    Scourzic L; Couronné L; Pedersen MT; Della Valle V; Diop M; Mylonas E; Calvo J; Mouly E; Lopez CK; Martin N; Fontenay M; Bender A; Guibert S; Dubreuil P; Dessen P; Droin N; Pflumio F; Weber M; Gaulard P; Helin K; Mercher T; Bernard OA
    Leukemia; 2016 Jun; 30(6):1388-98. PubMed ID: 26876596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Site- and allele-specific polycomb dysregulation in T-cell leukaemia.
    Navarro JM; Touzart A; Pradel LC; Loosveld M; Koubi M; Fenouil R; Le Noir S; Maqbool MA; Morgado E; Gregoire C; Jaeger S; Mamessier E; Pignon C; Hacein-Bey-Abina S; Malissen B; Gut M; Gut IG; Dombret H; Macintyre EA; Howe SJ; Gaspar HB; Thrasher AJ; Ifrah N; Payet-Bornet D; Duprez E; Andrau JC; Asnafi V; Nadel B
    Nat Commun; 2015 Jan; 6():6094. PubMed ID: 25615415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.
    Minning C; Mokhtar NM; Abdullah N; Muhammad R; Emran NA; Ali SA; Harun R; Jamal R
    Int J Oncol; 2014 Nov; 45(5):1959-68. PubMed ID: 25175708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low level CpG island promoter methylation predicts a poor outcome in adult T-cell acute lymphoblastic leukemia.
    Touzart A; Boissel N; Belhocine M; Smith C; Graux C; Latiri M; Lhermitte L; Mathieu EL; Huguet F; Lamant L; Ferrier P; Ifrah N; Macintyre E; Dombret H; Asnafi V; Spicuglia S
    Haematologica; 2020 Jun; 105(6):1575-1581. PubMed ID: 31537687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness.
    Bardelli V; Arniani S; Pierini V; Di Giacomo D; Pierini T; Gorello P; Mecucci C; La Starza R
    Genes (Basel); 2021 Jul; 12(8):. PubMed ID: 34440292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of genotype on survival of children with T-cell acute lymphoblastic leukemia treated according to the French protocol FRALLE-93: the effect of TLX3/HOX11L2 gene expression on outcome.
    Ballerini P; Landman-Parker J; Cayuela JM; Asnafi V; Labopin M; Gandemer V; Perel Y; Michel G; Leblanc T; Schmitt C; Fasola S; Hagemejier A; Sigaux F; Auclerc MF; Douay L; Leverger G; Baruchel A
    Haematologica; 2008 Nov; 93(11):1658-65. PubMed ID: 18835836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RNA-Seq reveals the existence of a CDKN1C-E2F1-TP53 axis that is altered in human T-cell lymphoblastic lymphomas.
    López-Nieva P; Fernández-Navarro P; Vaquero-Lorenzo C; Villa-Morales M; Graña-Castro O; Cobos-Fernández MÁ; López-Lorenzo JL; Llamas P; González-Sanchez L; Sastre I; Pollan M; Malumbres M; Santos J; Fernández-Piqueras J
    BMC Cancer; 2018 Apr; 18(1):430. PubMed ID: 29661169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergistic Cytotoxic Effect of L-Asparaginase Combined with Decitabine as a Demethylating Agent in Pediatric T-ALL, with Specific Epigenetic Signature.
    Serravalle S; Bertuccio SN; Astolfi A; Melchionda F; Pession A
    Biomed Res Int; 2016; 2016():1985750. PubMed ID: 28003999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA hypermethylation does not negatively impact the transcription of the TNF-α gene in an acute T-cell leukemia.
    Jayaraman A; Jayaraman S
    Epigenomics; 2019 Dec; 11(16):1753-1763. PubMed ID: 31755306
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer.
    Lee CJ; Ahn H; Jeong D; Pak M; Moon JH; Kim S
    BMC Med Genomics; 2020 Feb; 13(Suppl 3):27. PubMed ID: 32093698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Global DNA methylation profiling reveals new insights into epigenetically deregulated protein coding and long noncoding RNAs in CLL.
    Subhash S; Andersson PO; Kosalai ST; Kanduri C; Kanduri M
    Clin Epigenetics; 2016; 8():106. PubMed ID: 27777635
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeted DNA Methylation Profiling of Human Cardiac Tissue Reveals Novel Epigenetic Traits and Gene Deregulation Across Different Heart Failure Patient Subtypes.
    Glezeva N; Moran B; Collier P; Moravec CS; Phelan D; Donnellan E; Russell-Hallinan A; O'Connor DP; Gallagher WM; Gallagher J; McDonald K; Ledwidge M; Baugh J; Das S; Watson CJ
    Circ Heart Fail; 2019 Mar; 12(3):e005765. PubMed ID: 30798618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potential roles of microRNA-29a in the molecular pathophysiology of T-cell acute lymphoblastic leukemia.
    Oliveira LH; Schiavinato JL; Fráguas MS; Lucena-Araujo AR; Haddad R; Araújo AG; Dalmazzo LF; Rego EM; Covas DT; Zago MA; Panepucci RA
    Cancer Sci; 2015 Oct; 106(10):1264-77. PubMed ID: 26251039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The molecular profile of adult T-cell acute lymphoblastic leukemia: mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL.
    Grossmann V; Haferlach C; Weissmann S; Roller A; Schindela S; Poetzinger F; Stadler K; Bellos F; Kern W; Haferlach T; Schnittger S; Kohlmann A
    Genes Chromosomes Cancer; 2013 Apr; 52(4):410-22. PubMed ID: 23341344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.